Next Article in Journal
Effects of GPR18 Ligands on Body Weight and Metabolic Parameters in a Female Rat Model of Excessive Eating
Previous Article in Journal
Pipecolisporin, a Novel Cyclic Peptide with Antimalarial and Antitrypanosome Activities from a Wheat Endophytic Nigrospora oryzae
 
 
Review
Peer-Review Record

Plant Phenolics and Extracts in Animal Models of Preeclampsia and Clinical Trials—Review of Perspectives for Novel Therapies

Pharmaceuticals 2021, 14(3), 269; https://doi.org/10.3390/ph14030269
by Marcin Ożarowski 1,*, Tomasz M. Karpiński 2, Michał Szulc 3, Karolina Wielgus 1, Radosław Kujawski 3, Hubert Wolski 4,5 and Agnieszka Seremak-Mrozikiewicz 5,6,7
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Pharmaceuticals 2021, 14(3), 269; https://doi.org/10.3390/ph14030269
Submission received: 15 February 2021 / Revised: 6 March 2021 / Accepted: 13 March 2021 / Published: 16 March 2021
(This article belongs to the Section Natural Products)

Round 1

Reviewer 1 Report

In my view, the authors have made a good work in revising the literature existing to date on the field. This review seems enough clear and well organized. Just few concerns about unclear parts and English revision, which I grouped together in the attached file.

Comments for author File: Comments.pdf

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

Type of the Paper (Review)

Title: Plant phenolics and extracts in animal models of pre-eclampsia and clinical trials – review of perspectives for novel therapies

Minor error:

       1-Comments: Page 2, Line 73: Reference[7,8] instead of [7, 8], no space between the number, please check the similar mistake throughout the manuscript

      2-Comments: Need to uniform (write the same way): anti-hyperglycemic and antihyperglycemic; antihypertensive and anti-hypertensive; anti-oxidant and antioxidant; anti-inflammatory and antiinflammatory

           2a) Line 415: antihyperglycemic; Line 118: anti-hyperglycemic

            2b) Line 30, 50, 84, 78, 160, 381: anti-hypertensive; Line 119, 142, 416, 193, 432, 471, 615, 620, 844, 876: antihypertensive

           2c) Line 180: anti-oxidant; Line 50 77, 109, 118,471, 489, 506, 568, 573, 576 609, 634, 666, 785, 842, 866, 876: antioxidant

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Round 2

Reviewer 1 Report

The authors answered my concerns correctly, so I now believe the manuscript is worth publishing
Back to TopTop